Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-24 @ 11:30 PM
NCT ID:
NCT00180856
Eligibility Criteria:
Inclusion Criteria:
* Unilateral or bilateral unresectable primary or metastatic lung tumors \<= 40 mm and a number of tumor \<=5
* Tumors located more than 1 cm from the hilum, and not involving soft tissues or mediastinum.
* Malignancy histologically proven for pulmonary nodules in patients with no history of cancer outside the lung.
* Lung tumors in patients with a known distant cancer history, has to be either histologically proven or a demonstrated change in size of at least 25% in their largest diameter is required on CT during the previous year
* Pretreatment imaging work-up within 4 weeks of scheduled RF ablation (at least a chest CT and an abdomino-pelvic CT)
* If a tumor is found outside the lung, it has to be amenable to complete eradication with RF or RF plus surgery
* Lung spirometry within 4 weeks of treatment with a FEV1 \>= 1 liter
* Written informed consent.
Exclusion Criteria:
* Uncorrectable coagulopathy with a prothrombin time greater than 1.5 and a platelet count below 106/mm3
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00180856
Study Brief:
Protocol Section:
NCT00180856